Skip to content

Screener

Eligibility screening

A Phase 1 Clinical Trial of NXP900 in Subjects With Advanced Cancers

Sponsored by Nuvectis Pharma, Inc.Study detailsClinicalTrials.gov

10 US sites in AZ, CO, FL, IL +4

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.